Holen Sie sich die Stockscreener-App
12.78
0.12%
-0.015
Handel nachbörslich:
12.78
0.005
+0.04%
Schlusskurs vom Vortag:
$12.79
Offen:
$12.79
24-Stunden-Volumen:
436.46K
Relative Volume:
1.22
Marktkapitalisierung:
$527.85M
Einnahmen:
$313.73M
Nettoeinkommen (Verlust:
$-31.39M
KGV:
-16.82
EPS:
-0.7597
Netto-Cashflow:
$-3.53M
1W Leistung:
-1.58%
1M Leistung:
+5.58%
6M Leistung:
+26.86%
1J Leistung:
+37.07%
1-Tages-Spanne:
$12.71
$13.01
1-Wochen-Bereich:
$12.55
$13.26
52-Wochen-Spanne:
$8.36
$13.99
Angiodynamic Inc Stock (ANGO) Company Profile
Firmenname
Angiodynamic Inc
Sektor
Telefon
(518) 798-1215
Adresse
14 PLAZA DRIVE, LATHAM
Compare ANGO vs ISRG, BDX, MDLN, ALC, RMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ANGO
Angiodynamic Inc
|
12.78 | 528.47M | 313.73M | -31.39M | -3.53M | -0.7597 |
ISRG
Intuitive Surgical Inc
|
407.12 | 144.07B | 10.58B | 3.00B | 2.83B | 8.2437 |
BDX
Becton Dickinson Co
|
153.83 | 41.87B | 21.37B | 1.41B | 3.07B | 3.9437 |
MDLN
Medline Inc
|
40.58 | 34.70B | 29.14B | 1.07B | 1.05B | 1.1956 |
ALC
Alcon Inc
|
69.00 | 33.07B | 10.63B | 819.00M | 1.59B | 1.6577 |
RMD
Resmed Inc
|
198.50 | 29.57B | 5.54B | 1.52B | 1.74B | 10.37 |
Angiodynamic Inc Stock (ANGO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-16 | Eingeleitet | Lake Street | Buy |
| 2024-04-05 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2023-09-25 | Eingeleitet | H.C. Wainwright | Buy |
| 2023-04-17 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2021-10-15 | Hochstufung | Canaccord Genuity | Hold → Buy |
| 2021-08-20 | Eingeleitet | Oppenheimer | Perform |
| 2020-11-25 | Hochstufung | Raymond James | Mkt Perform → Strong Buy |
| 2020-04-08 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2019-04-01 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2018-04-03 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2018-01-05 | Herabstufung | Craig Hallum | Buy → Hold |
| 2017-04-07 | Bestätigt | Cantor Fitzgerald | Overweight |
| 2017-03-30 | Herabstufung | KeyBanc Capital Mkts | Overweight → Sector Weight |
| 2017-02-08 | Eingeleitet | Barclays | Equal Weight |
| 2016-11-04 | Eingeleitet | Cantor Fitzgerald | Buy |
| 2016-04-08 | Fortgesetzt | Piper Jaffray | Neutral |
| 2016-01-08 | Bestätigt | Canaccord Genuity | Buy |
| 2015-11-10 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2015-07-24 | Eingeleitet | KeyBanc Capital Mkts | Overweight |
| 2014-06-19 | Hochstufung | Canaccord Genuity | Hold → Buy |
| 2012-10-09 | Bestätigt | Canaccord Genuity | Hold |
| 2012-06-25 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2011-07-15 | Hochstufung | Canaccord Genuity | Hold → Buy |
| 2011-07-15 | Hochstufung | Stifel Nicolaus | Hold → Buy |
| 2011-06-14 | Herabstufung | Wedbush | Neutral → Underperform |
| 2010-09-08 | Bestätigt | Wedbush | Neutral |
Alle ansehen
Angiodynamic Inc Aktie (ANGO) Neueste Nachrichten
AngioDynamics Inc expected to post a loss of 9 cents a shareEarnings Preview - TradingView
ANGOAngiodynamic Inc Latest SEC Filings - Finviz
Price to sales forward of AngioDynamics, Inc. – NASDAQ:ANGO - TradingView
Price to sales forward of AngioDynamics, Inc. – LS:A0B9A5 - TradingView
Press Release: AngioDynamics to Report Fiscal 2026 Fourth Quarter and Full-Year Financial Results on July 14, 2026 - Moomoo
AngioDynamics sets July 14 call for fiscal 2026 results - Stock Titan
AngioDynamics, Inc.(NasdaqGS: ANGO) added to Russell 2000 Value-Defensive Index - marketscreener.com
AngioDynamics, Inc. Actuals & Estimates (NASDAQ:ANGO) - TradingView
ANGO Forecast — Price Target — Prediction for 2027 - TradingView
Reasons to Hold AngioDynamics Stock in Your Portfolio for Now - TradingView
AngioDynamics Inc (ANGO) Valuation: PE, PB & Fair Value Analysis - TradingKey
AngioDynamics Inc (ANGO) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
AngioDynamics wins FDA okay to test NanoKnife in BPH patients - Stock Titan
AngioDynamics Inc (ANGO) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
AngioDynamics Inc (ANGO) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
AngioDynamics Inc (ANGO) Institutional Confidence - TradingKey
AngioDynamics Inc (ANGO) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
AngioDynamics, Inc. (ANGO) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026Slideshow - Seeking Alpha
ANGO News | ANGIODYNAMICS INC (NASDAQ:ANGO) - ChartMill
Port Catheter Thrombosis Lawsuit Claims Defective AngioDynamics Xcela Device Caused Injury - AboutLawsuits.com
ANGO Technical Analysis & Stock Price Forecast - Intellectia AI
ANGO Stock Price, Quote & Chart | ANGIODYNAMICS INC (NASDAQ:ANGO) - ChartMill
Webcast set for AngioDynamics talk at Goldman Sachs health event - Stock Titan
Reasons to Add AngioDynamics Stock to Your Portfolio for Now - Yahoo Finance
Point72 (ANGO) reports 3.18M shares, 7.7% stake via Point72 Associates - Stock Titan
Prostate cancer trial sees 0 new failures with NanoKnife at 2 years - Stock Titan
Wall Street Analysts Think AngioDynamics (ANGO) Could Surge 64.23%: Read This Before Placing a Bet - Yahoo Finance
AngioDynamics alleges patent infringement by E2 over clot removal technology - MassDevice
[8-K] ANGIODYNAMICS INC Reports Material Event - Stock Titan
Fair Value Assessment | AngioDynamics Inc. posts 117.8% EPS surprise beating loss estimatesEarnings Risk - Cổng thông tin điện tử tỉnh Tây Ninh
AngioDynamics files patent lawsuit against Endovascular Engineering - Investing.com
ANGO (AngioDynamics Inc.) notches massive Q1 2026 EPS beat, but shares fall 1.24 percent on slight year over year revenue decline.Social Trade Signals - Xã Thanh Hà
AngioDynamics (ANGO) Upgraded to Buy: Here's Why - Yahoo Finance
ANGO Stock Up in Pre-Market Post Q3 Earnings Beat, Gross Margin Down - TradingView
AngioDynamics Growing, But With More Noise Than The Street Likes (NASDAQ:ANGO) - Seeking Alpha
AngioDynamics Inc. Q3 2026 Financial Results: Revenue, Net Loss, and Key Financial Statements Overview - Minichart
AngioDynamics, Inc. (NASDAQ:ANGO) Q3 2026 Earnings Call Transcript - Insider Monkey
AngioDynamics (NASDAQ: ANGO) Q3 2026 revenue up 9% while net loss grows - Stock Titan
AngioDynamics, Inc. Q3 2026 Earnings Call Summary - Yahoo Finance
AngioDynamics, Inc. 2026 Q3ResultsEarnings Call Presentation (NASDAQ:ANGO) 2026-04-02 - Seeking Alpha
AngioDynamics Inc (NASDAQ:ANGO) Beats Q3 Earnings Estimates and Raises Full-Year Guidance - ChartMill
ANGIODYNAMICS ($ANGO) Releases Q3 2026 Earnings | ANGO Stock News - Quiver Quantitative
AngioDynamics Inc expected to post a loss of 11 cents a shareEarnings Preview - TradingView
AngioDynamics investors can watch Needham conference webcast April 14 - Stock Titan
Short Interest in AngioDynamics, Inc. (NASDAQ:ANGO) Decreases By 18.0% - Defense World
AngioDynamics, Inc. (NASDAQ:ANGO) Receives Average Recommendation of "Moderate Buy" from Brokerages - MarketBeat
AngioDynamics, Inc. (ANGO) Investor Outlook: Unpacking A 71.55% Potential Upside - DirectorsTalk Interviews
Vanguard disaggregates holdings; reports 0 shares in AngioDynamics (ANGO) - Stock Titan
AngioDynamics, Inc. (ANGO) Stock Analysis: A Potential 81.88% Upside For Investors - DirectorsTalk Interviews
AngioDynamics schedules April 2 earnings call before market open - Stock Titan
Bard And AngioDynamics Resolve 11-Year Patent Dispute - Law360
Finanzdaten der Angiodynamic Inc-Aktie (ANGO)
Umsatz
Nettogewinn
Free Cashflow
ENV
Angiodynamic Inc-Aktie (ANGO) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Trowbridge Stephen A | EVP and CFO |
Oct 13 '25 |
Buy |
11.16 |
890 |
9,932 |
256,629 |
| Clemmer James C | President and CEO |
Oct 09 '25 |
Buy |
11.15 |
10,000 |
111,500 |
882,529 |
0.22%
0.64%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):